EP1824756B1 - Primärverpackungseinheit für flächenförmige darreichungsformen - Google Patents

Primärverpackungseinheit für flächenförmige darreichungsformen Download PDF

Info

Publication number
EP1824756B1
EP1824756B1 EP05809149A EP05809149A EP1824756B1 EP 1824756 B1 EP1824756 B1 EP 1824756B1 EP 05809149 A EP05809149 A EP 05809149A EP 05809149 A EP05809149 A EP 05809149A EP 1824756 B1 EP1824756 B1 EP 1824756B1
Authority
EP
European Patent Office
Prior art keywords
packaging unit
unit according
primary packaging
packaging
primary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP05809149A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1824756A1 (de
Inventor
Ingo Lehrke
Ulrike Vollmer
Stephan Maier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labtec GmbH
Original Assignee
Labtec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labtec GmbH filed Critical Labtec GmbH
Publication of EP1824756A1 publication Critical patent/EP1824756A1/de
Application granted granted Critical
Publication of EP1824756B1 publication Critical patent/EP1824756B1/de
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding

Definitions

  • the present invention relates to a primary packaging unit for sheet-like administration forms with active ingredients, each having a section of packaging material and each having one or more sections of Packstoffober- and -unterbahn, the dosage forms and the packaging material upper and Unterbahn on mutually opposite sides of the packaging material are dimensioned and wherein the packaging material center line is dimensioned according to a card in which the packaging material web is rigid and represents the basis of the card, the packaging material web is a thin film with water vapor barrier properties, the packaging material web is a thin film with water vapor barrier properties and multiple dose units together with the individual components Map by sealing or gluing on an in-line packaging machine are connected to one another so that the sheet-like dosage forms individually ve remain packed even if one of the dosage forms is removed.
  • Flat administration forms in the context of this application are, for example, topically applied cosmetic, medicinal or active ingredient-containing patches such as wart plasters, insect stick plasters or nail plasters, mucoadhesive gingiva patches or oral oral films.
  • This dosage form is particularly suitable for travel or for activities or situations in which a quick and convenient intake of the medication without liquid is desired.
  • sheet-like dosage form in the context of this application and highlighting is that these forms of delivery especially on the road, for example, when traveling, to provide quick help. Ideally, these forms of administration can therefore be comfortably and inconspicuously carried by the user as well as always at hand, for example in the wallet, shirt or trouser pocket.
  • the dosage forms can be drugs, individual packaging of each single dose must be realized.
  • the primary packaging unit proposed there consists only of one section each of a packaging material upper and lower web, whereby the available area of the primary packaging unit is used only on one side.
  • twice the area is required for the primary packaging unit.
  • sheet-like administration forms of a particularly preferred size of 4-7 cm 2 if one still wants to carry a reasonable number of individual doses, this leads to such a large packaging unit that it can no longer be comfortably carried along the body without bending it. which, however, may compromise the integrity of the package and thus the dosage form.
  • a primary packaging unit for sheet-like dosage forms with active ingredients is already known, in which a packaging material web is rigid and designed as the basis for the packaging unit.
  • Packaging material webs for fixing and enclosing the dosage forms are formed like a film and provided with water vapor barrier properties.
  • the film-shaped webs are connected to the packaging material middle web to form a unit.
  • a primary packaging unit for sheet-like dosage forms ( Fig.2 . 4 ), with a section of a rigid packaging material middle web ( Fig.2, 1 ) and each with one or more sections of a flexible packaging upper and lower web ( Fig.2, 2 ), which is characterized in that the rigid packaging material middle web, on which a variable number of sheet-like administration forms can be applied on both sides ( 2b ), are connected on one side with one or more sections of flexible packaging material web and on the opposite side with one or more sections of flexible packaging material web by sealing or gluing together so that a solid but flexible card of maximum 1mm thickness is obtained, in which the sheet-like dosage forms are individually packaged and remain, even if one of the several dosage forms is removed without the card has a perforation between the individually packaged dosage forms.
  • a rapid card in any size is possible, but particularly preferred is an embodiment that corresponds in size to a credit card, as in Fig.1 and 2 shown.
  • This standardized measure makes it possible to carry the Rapidcard conveniently in the breast pocket, a shirt, the back pocket of a pair of trousers or in the purse.
  • a variant is particularly preferred in which 2-10 area-shaped dosage forms of 2-10 cm 2 area, more preferably 3 area-shaped dosage forms of 4-7 cm 2 area are packed on each side of the card.
  • a carrier film for example, from PE, PP, PVC, PETG, PETGAG, COC or multilayer laminates such as PE / paper / PE, PE / PVC / PE, etc., 6 rectangular, surface-shaped dosage forms of 6 cm 2 area are applied ,
  • three dosage forms are applied to both the front and on the back of the carrier film so that they do not touch each other and a sufficient distance between them to each dosage form individually by sealing or gluing one or more sections of a flexible packaging material or to completely enclose the underground and thus protect it against external influences (cf. 2b ).
  • the packaging material upper or lower web is a sheet-like, thin material of a maximum thickness of 0.2 mm, which is a barrier to atmospheric moisture and atmospheric oxygen ( Fig.2, 2 and Fig. 4 , hereinafter referred to as protective film).
  • protective film After sealing or gluing, this material must have the property of being peelable, that is, after one or more sections of this protective film have been sealed or glued to the rigid support film, it must be possible to use it at a later time with little Remove the force again from the carrier film to remove the appropriate dosage form.
  • film-like materials with different barrier properties come into question, depending on the properties of the dosage forms to be packaged.
  • a transparent film with barrier properties to humidity such as PE / PCTFE / PE can be used if the product is to be visible and there is no photosensitivity.
  • the PCTFE must have a minimum thickness of 50 ⁇ m.
  • a film may be used which is colored or coated or contains an aluminum layer, whereby In addition to the sunscreen protection against moisture and atmospheric oxygen is given.
  • the machine parameters during the sealing or gluing process as well as the width of the sealing seam or adhesive surface obtained in the corresponding method are chosen such that the product is efficiently protected against external factors influencing stability for the period of the determined durability, and nevertheless at a later point in time easy opening of the sealing seam or adhesive surface for removal is possible.
  • the one or more sections of the protective film are - should this not already be given by the nature of the sealing or gluing process - further in such a way that it is possible to open the seal or adhesive surface only an individual dosage form and remove it without opening or damaging the protective packaging of a neighboring dosage form. This can be achieved, for example, by virtue of the protective film having an incision at the sealing seam or adhesive surface between the individual dosage forms ( Fig.2 . 5 ).
  • the protective film can be designed so that it has a pull tab for easier opening for each individual dosage form.
  • a pull tab is a part of the protective film, which is in direct contact with the individually packaged dosage form, but is not connected by sealing, gluing or other measures with the carrier film, but rests loosely on the carrier film.
  • the sealing seam or adhesive surface of the corresponding area of the card can be opened and the planar dosage form removed.
  • a predetermined breaking point can also be provided here.
  • Both the carrier film and the protective films can be printed with information if required ( Fig. 1 ).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
EP05809149A 2004-11-23 2005-11-09 Primärverpackungseinheit für flächenförmige darreichungsformen Not-in-force EP1824756B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004056576A DE102004056576A1 (de) 2004-11-23 2004-11-23 Rapidcard
PCT/DE2005/002006 WO2006056161A1 (de) 2004-11-23 2005-11-09 Primärverpackungseinheit für flächenförmige darreichungsformen

Publications (2)

Publication Number Publication Date
EP1824756A1 EP1824756A1 (de) 2007-08-29
EP1824756B1 true EP1824756B1 (de) 2010-03-17

Family

ID=35655531

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05809149A Not-in-force EP1824756B1 (de) 2004-11-23 2005-11-09 Primärverpackungseinheit für flächenförmige darreichungsformen

Country Status (7)

Country Link
US (1) US20080116104A1 (es)
EP (1) EP1824756B1 (es)
AT (1) ATE461128T1 (es)
CA (1) CA2595110A1 (es)
DE (2) DE102004056576A1 (es)
ES (1) ES2342546T3 (es)
WO (1) WO2006056161A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2248519T3 (pl) 2006-10-02 2018-04-30 Apr Applied Pharma Research S.A. Niemukoadhezyjne postaci dawkowania w postaci filmu
USD837066S1 (en) 2017-09-14 2019-01-01 Split Nutrition, LLC Multi-compartment food package
USD859178S1 (en) 2017-09-14 2019-09-10 Split Nutrition, LLC Multi-compartment food package
USD875548S1 (en) 2017-09-14 2020-02-18 Split Nutrition, LLC Multi-compartment food package
USD866344S1 (en) 2017-09-14 2019-11-12 Good Seed Snack Company, LLC Multi-compartment food package

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2779465A (en) * 1954-04-13 1957-01-29 Anderson Orval William Composite disposable pad
US3540579A (en) * 1968-03-27 1970-11-17 Hellstrom Harold R Individualized dispensing packages
US3521805A (en) * 1968-09-27 1970-07-28 Anderson Bros Mfg Co Dispensing packet
US3603453A (en) * 1969-06-09 1971-09-07 Parke Davis & Co Pharmacal package construction
US3861529A (en) * 1970-10-16 1975-01-21 Picker Corp Package and method of making
DE2532958A1 (de) * 1974-08-22 1976-03-04 Schreiber Cheese Co L D Verpackung und verfahren zu deren herstellung
US3966045A (en) * 1975-05-12 1976-06-29 W. R. Grace & Co. Skin package
US4911304A (en) * 1989-03-20 1990-03-27 Merck & Co., Inc. Sandwich blister package for tablets and similar articles
DK294090A (da) * 1990-12-11 1992-06-12 Kokkedyd Aps Foedevareemballage
US5511689A (en) * 1993-12-28 1996-04-30 Frank; Richard D. Dispensing device for adhesive-backed articles
DE19715550C1 (de) * 1997-04-15 1998-05-20 Becker Industrievertretungen G Verfahren zum Skinverpacken von Packgut und Skinverpackung
DE29823463U1 (de) * 1998-01-10 1999-07-22 LTS Lohmann Therapie-Systeme GmbH, 56567 Neuwied Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
WO2002013762A2 (en) * 2000-08-10 2002-02-21 Delsys Pharmaceutical Corporation Improved solid pharmaceutical dosage formulation of hydrophobic drugs
SE516478C2 (sv) * 2001-04-25 2002-01-22 Ragnar Winberg Blisterförpackning
US6726054B2 (en) * 2002-03-29 2004-04-27 Tapemark Dispenser package arrangement and methods
US6818269B2 (en) * 2002-09-27 2004-11-16 Dot Packaging Group, Inc. Metallic board
US6708826B1 (en) * 2003-04-30 2004-03-23 Warner-Lambert Company, Llc Packaged supply of individual doses of a personal care product

Also Published As

Publication number Publication date
EP1824756A1 (de) 2007-08-29
US20080116104A1 (en) 2008-05-22
DE102004056576A1 (de) 2006-05-24
WO2006056161A1 (de) 2006-06-01
CA2595110A1 (en) 2006-06-01
ATE461128T1 (de) 2010-04-15
ES2342546T3 (es) 2010-07-08
DE502005009254D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
EP1799579B1 (de) Peelfähige, kindersichere verpackung für filmförmige arzneiformen
DE19853737C2 (de) Verfahren zum Spenden von flächigen Gebilden
DE69518759T2 (de) Verwandelbare, kindersichere blisterpackung
EP2059455B1 (de) Verpackung für wirkstoffhaltige filme und verfahren für deren herstellung
EP1140650B1 (de) Verpackung für flächenförmige gebilde/produkte
DE69506267T2 (de) Blisterpackung mit trockenmittel
EP1824756B1 (de) Primärverpackungseinheit für flächenförmige darreichungsformen
DE202004021140U1 (de) Neue Arzneimittelverpackung
EP1161375B1 (de) Sammelpackung zur entnahme von befüllten beuteln in vorgegebener reihenfolge
EP0705204B1 (de) Beutelverpackung für flüssige arzneimittel
WO1999035051A1 (de) Primärverpackungseinheit für film- oder oblatenartige darreichungsformen
DE102010028361A1 (de) Wafertasche mit aufreißbarem Waferaufnahmefach
EP2874908B1 (de) Verpackung für einzeldosierte wirkstoffhaltige filme und verfahren zur herstellung dieser verpackung
WO2007028507A1 (de) Wafervial mit inerten zwischenlagen
DE10008165A1 (de) Verpackung flächenförmiger Gegenstände mit verbesserter Aufreisseigenschaft
EP1594761B1 (de) Primärverpackung als applikator
DE102010028351A1 (de) Wafertasche
DE3931019C2 (es)
EP2521114B1 (de) Aufhängeetikett für einen Flüssigkeitsbeutel und Verfahren zum Anbringen eines Etiketts an einem mit Flüssigkeit gefüllten Beutel
DE19820999A1 (de) Laminat zum Aufbringen auf einen Akzeptor
WO2002038138A2 (de) Primärverpackung für transdermale therapeutische systeme oder medizinische pflaster
DE202006005907U1 (de) Aufhänge- und Kennzeichnungsvorrichtung
DE29823463U1 (de) Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen
CH570907A5 (en) Sensitive item sheet packing - has pull-off flexible sheet attached to rigid one forming pockets
EP2999443B1 (de) Pflaster mit abziehhilfe

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080729

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LABTEC GMBH

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 502005009254

Country of ref document: DE

Date of ref document: 20100429

Kind code of ref document: P

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2342546

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20100317

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20100317

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100618

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100717

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100617

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100719

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

26N No opposition filed

Effective date: 20101220

BERE Be: lapsed

Owner name: LABTEC G.M.B.H.

Effective date: 20101130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101130

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 461128

Country of ref document: AT

Kind code of ref document: T

Effective date: 20101109

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101109

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100918

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101109

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100317

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502005009254

Country of ref document: DE

Representative=s name: KOENIG SZYNKA TILMANN VON RENESSE PATENTANWAEL, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 502005009254

Country of ref document: DE

Owner name: APR APPLIED PHARMA RESEARCH S.A., CH

Free format text: FORMER OWNER: LABTEC GMBH, 40764 LANGENFELD, DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: APR APPLIED PHARMA RESEARCH S.A., CH

Effective date: 20151027

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20151105 AND 20151111

REG Reference to a national code

Ref country code: FR

Ref legal event code: CD

Owner name: APR APPLIED PHARMA RESEARCH S.A., CH

Effective date: 20151027

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: APR APPLIED PHARMA RESEARCH S.A.

Effective date: 20180110

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20181128

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20181127

Year of fee payment: 14

Ref country code: IT

Payment date: 20181123

Year of fee payment: 14

Ref country code: GB

Payment date: 20181127

Year of fee payment: 14

Ref country code: ES

Payment date: 20181203

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502005009254

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20191109

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200603

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191130

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191109

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191109

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20210414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191110